The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeorgia Capital Regulatory News (CGEO)

Share Price Information for Georgia Capital (CGEO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,332.00
Bid: 1,330.00
Ask: 1,336.00
Change: 18.00 (1.37%)
Spread: 6.00 (0.451%)
Open: 1,314.00
High: 1,340.00
Low: 1,314.00
Prev. Close: 1,314.00
CGEO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Georgia Capital plc

18 May 2020 12:12

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: COELI FRONTIER MARKETS AB
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

OFFEROR: Georgia Capital plc, GB00BF4HYV08

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

2020-05-14
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

OFFEREE: Georgia Healthcare Group plc, GB00BYSS4K11

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 1p ordinary

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 621 865 1,548
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

621 865 1,548

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit
1p ordinary Sale 24287 4,1828

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 2020-05-18
Contact name: Joakim Lundmark
Telephone number*: +46 (0)709379752

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200518005361/en/

Copyright Business Wire 2020

Date   Source Headline
2nd Nov 20233:03 pmRNSTransaction in Own Shares
1st Nov 20235:31 pmRNSTransaction in Own Shares
1st Nov 20234:40 pmRNSTotal Voting Rights
31st Oct 20235:29 pmRNSTransaction in Own Shares
31st Oct 20237:00 amRNS3rd Quarter Results
18th Oct 20239:38 amRNSNotice of Results
3rd Oct 20237:15 amEQSGeorgia Capital (GCAP): Successful bond refinancing improves risk profile
25th Sep 20235:32 pmRNSDirector/PDMR Shareholding
4th Sep 202310:06 amRNSAnnouncement of Redemption Price
15th Aug 20237:00 amRNSHalf-year Report
9th Aug 20234:15 pmRNSNotice of make-whole redemption
9th Aug 202310:52 amRNSResult of Tender Offer
2nd Aug 20231:00 pmRNSNotice of Results
1st Aug 20237:00 amRNSJSC Georgia Capital prices a bond offering
12th Jul 20237:34 amRNSTender Offer
12th Jul 20237:00 amRNSJSC Georgia Capital launches a bond offering
3rd Jul 202310:47 amRNSTotal Voting Rights
29th Jun 20232:17 pmRNSGeorgia Capital to consider bond issuance
27th Jun 20233:24 pmRNSCancellation of Treasury Shares
20th Jun 202311:27 amRNSTransaction in Own Shares
19th Jun 20235:22 pmRNSTransaction in Own Shares
6th Jun 20235:35 pmRNSTransaction in Own Shares
5th Jun 20235:14 pmRNSTransaction in Own Shares
2nd Jun 20235:00 pmRNSCancellation of Treasury Shares
1st Jun 20234:41 pmRNSTransaction in Own Shares
1st Jun 20231:01 pmRNSTotal Voting Rights
31st May 20235:26 pmRNSTransaction in Own Shares
26th May 20232:14 pmRNSTransaction in Own Shares
26th May 20237:15 amRNSEdison issues update on Georgia Capital (GCAP)
25th May 20235:32 pmRNSTransaction in Own Shares
23rd May 20235:31 pmRNSTransaction in Own Shares
19th May 20235:23 pmRNSTransaction in Own Shares
19th May 20235:22 pmRNSDirector/PDMR Shareholding
19th May 20234:22 pmRNSDirector/PDMR Shareholding
17th May 20235:51 pmRNSTransaction in Own Shares
17th May 202312:37 pmRNSResult of AGM
15th May 20235:29 pmRNSTransaction in Own Shares
11th May 20233:57 pmRNSTransaction in Own Shares
10th May 20235:25 pmRNSTransaction in Own Shares
10th May 20237:00 amRNS1st Quarter Results
5th May 20235:22 pmRNSTransaction in Own Shares
3rd May 20237:00 amRNSNotice of Results
2nd May 20234:57 pmRNSHolding(s) in Company
2nd May 20232:38 pmRNSTransaction in Own Shares
2nd May 202311:19 amRNSTotal Voting Rights
2nd May 20239:37 amRNSDirector/PDMR Shareholding
28th Apr 20234:52 pmRNSTransaction in Own Shares
28th Apr 20234:13 pmRNSCancellation of Treasury Shares
27th Apr 20234:38 pmRNSTransaction in Own Shares
26th Apr 20233:44 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.